“…It has been emphasized that this classification of the adrenergic receptors into two types agrees well with the antagonists of catecholamines much more than with the amines themselves (18). The element of uncertainty that lies in fitting metabolic, intestinal, cardiac, and CNS effects of catecholamines into this scheme is a challenge in itself, and there is no clear evidence as to whether differences between alpha-and beta-receptors are related t o basic structural features, to flexible conformational variants, or to relative accessibility of receptors (19). The evolution of alpha-and beta-receptor-blocking agents, a term coined by Moran and Perkins (20), in the last two decades is the immediate consequence of Ahlquist's classification.…”